NFE2L2 and neurodegenerative disease: As a master regulator of the antioxidant mechanism (and also involved in the anti-inflammatory mechanism), the redox transcription factor, nuclear factor erythroid 2-related factor 2 (Nrf2), has emerged recently as a valid therapeutic target for AD and a number of other neurodegenerative diseases [100,101,102].